Please assess the completion status of the following clinical trial:

Trial Title: Non-invasive Risk Stratification of CR AMN/SSP

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Individuals capable and willing of proving satisfactory informed consent~* Individuals with colonic lesions larger than 20mm~* Individuals diagnosed with laterally spreading or sessile polyp morphology~* Individuals schedules for screening colonoscopy and with no prior history of CRC~* Ability and willingness to collect stool sample at home~* Ability and willingness to undergo venepuncture procedure~Exclusion Criteria:~* Individuals not able or unwilling to provide informed consent~* Individuals less than 18 year of age~* Individuals who undergo an incomplete colonoscopy or resection, which raises doubt as to the status of the colon (post-hoc exclusion)~* Individuals with a prior history of CRC~* Individuals with a history of Irritable Bowel Disease (IBD), hereditary nonpolyposis colorectal cancer (HNPCC) or Familial adenomatous polyposis (FAP)~* Individuals with bleeding diathesis~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Normal subjects (Type: None): blood or stool samples will be collected from people referred for screening colonoscopy
- Colorectal cancer (Type: None): blood or stool samples will be collected from people with colorectal cancer detected at colonoscopy or resection
- Polyps <10mm and no high risk features (Type: None): blood or stool samples will be collected from people with no polyps or low risk polyps (\<10mm, no villous component or dysplasia) detected at colonoscopy
- Advanced Mucosal Neoplasia (Type: None): blood or stool samples will be collected from people with AMN detected at resection
- Sessile Serrated Adenoma (Type: None): blood or stool samples will be collected from people with SSP detected at resection
- non-colorectal neoplastic disease (Type: None): Participants with disease that is not colorectal neoplasia. Analysis of this cohort is not a primary endpoint but the investigators will report assay positivity in this group on an opportunistic basis. This cohort will include patients diagnosed with, for example, inflammatory bowel disease or extracolonic cancer.

Based on this trial design, predict the completion outcome and termination type (if applicable).